オプション
AIプロンプト一覧 医療健康 家庭常備薬有効期限整理リマインダーリスト

家庭常備薬有効期限整理リマインダーリスト

{:__('collect %s',家庭常備薬有効期限整理リマインダーリスト)}

利用者が提供した家庭常備薬の情報を基に、整理された有効期限リマインダーリストを作成し、3か月以内に期限切れる薬品をマークします。

プロンプト内容 コピー コピー

Based on the types, current storage locations and existing storage duration of common household standing medicines provided by users, sort out a clear medicine expiry reminder list, mark key reminders for medicines that expire in less than three months, give reasonable storage adjustment suggestions, and do not provide any diagnosis or treatment suggestions throughout the process, only for sorting and reminder.

コピー コピー

利用者が提供した家庭常備薬の種類、現在の保管場所、保管期間に基づき、明確な薬品の有効期限リマインダーリストを整理し、有効期限まで3か月に満たない薬品を重点的にマークし、合理的な保管調整案を提示し、全過程で診療提案を一切行わず、整理とリマインドのみを行います。

コピー コピー
コメント (0)
0/300

おすすめ

処方箋審査アシスタント
Act as an intelligent audit assistant for a hospital pharmacy. Perform a deep compliance check on the provided electronic prescription data. First, extract patient demographics, diagnosis, and the list of prescribed medications, focusing on analyzing potential drug-drug interactions, especially for elderly patients or those with hepatic/renal impairment. Second, cross-reference medication contraindications with the patient's medical history and allergies, and identify any off-label usage. Finally, generate a structured audit report that clearly highlights potential risks, recommends safe alternative options or dosage adjustments, and flags items requiring manual pharmacist review, ensuring the prescription adheres to clinical medication guidelines before dispensing.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided electronic prescription for compliance. Focus on analyzing the patient's current medication list for potential drug interactions, contraindication conflicts, or dosages exceeding recommended ranges. If risks are identified, point out specific issues based on the latest clinical guidelines and provide adjustment suggestions; if no anomalies exist, confirm that the prescription meets standard treatment protocols.
処方審査アシスタント
Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Valsartan 80mg once daily, and Ibuprofen 400mg three times daily for joint pain. Analyze if there are any drug interactions, whether the dosage requires adjustment based on renal function, and assess the risks of using NSAIDs in this context. Provide specific adjustment suggestions or alternative solutions to ensure medication safety.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Cross-reference with the patient's medical history and allergy records to flag potential risks and suggest adjustments, ensuring the treatment plan aligns with the latest clinical guidelines.
処方箋コンプライアンス審査
Act as a senior clinical pharmacist to review the following patient prescription: The patient is a 65-year-old male diagnosed with Stage 2 Hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and a newly prescribed Ibuprofen 400mg three times daily for joint pain. Analyze if this prescription contains any drug-disease contraindications, drug-drug interactions, or dosage adjustment needs, specifically focusing on the risks of using NSAIDs in patients with renal impairment. Provide specific adjustment suggestions or alternative solutions to ensure medication safety and compliance with clinical guidelines.
処方箋審査アシスタント
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring the safety and efficacy of the medication regimen.
OR